smartbax
smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
1
Funding Rounds
$1.3m
Money raised
Overview
smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
- Website:
- Headquarters: Munich
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company smartbax has raised a total of $1.3m in funding over 1 rounds.
Key Insights:
- smartbax May 2023 Seed Funding Round: $1.3m
smartbax May 2023 Seed Funding Round
$1.3m